Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast after endovascular treatment for peripheral arterial occlusive disease
2020-000715-71Phase 2Active
- Sponsor
- Jagiellonian University Medical College
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of montelukast in arteriosclerosis obliterans and atherosclerosis, sponsored by Jagiellonian University Medical College. Primary endpoint: Restenosis in a previously treated artery. Started Jan 2021; status: active.
02
Drugs
montelukast
03
Conditions
arteriosclerosis obliteransatherosclerosis
Beyond the preview
Go deeper on 2020-000715-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000715-71.